In a defining moment for GN Group and Amplifon, a look at the kind of leadership that prioritizes discipline, focus, and long-term value over visibility.
This week’s Current Climate newsletter also looks at how SpaceX’s IPO could leave Tesla eating rocket dust and the need for better forest management in a warming world
Trump’s orders move the U.S. a few steps closer to more widespread research on and use of two sets of controversial yet promising drugs, psychedelic and cannabis products
Chromolume.io synthesizes the gross weekly box office receipts of Broadway shows to create industry power rankings.
Mark Cuban’s Cost Plus Drug Company and Humana’s CenterWell Pharmacy confirmed they have formed a partnership “to develop new end-to-end employer prescription solutions.”
Spotify is launching a fitness category with hundreds of workouts and dozens of playlists for its many users who workout regularly.
Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market and patients flock to them.
Mariana Minerals is operating what it says is the world’s first autonomous mine, extracting and refining copper in Utah to meet surging demand for the costly metal.
What do experts expect for Microsoft stock in 2026? Read this analysis of MSFT’s growth trends and analyst price targets for the 2026 fiscal year to get a better idea.
A recent attack on Sam Altman’s home and OpenAI offices has put corporate security under renewed scrutiny. Records reveal how much some tech firms spend to arm up.